Page last updated: 2024-08-18

dimethyldioctadecylammonium and Koch's Disease

dimethyldioctadecylammonium has been researched along with Koch's Disease in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (44.44)	29.6817
2010's	5 (55.56)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Christensen, D; Khadke, S; Perrie, Y; Roces, CB	1
Li, J; Li, R; Lin, X; Liu, W; Niu, H; Tan, J; Wang, Y; Wu, Y; Xin, Q; Yu, H; Zhu, B	1
Amel Jamehdar, S; Amini, Y; Badiee, A; Ghazvini, K; Jaafari, MR; Mansury, D; Nikpoor, AR; Tafaghodi, M	1
Andersen, P; Christensen, D; Foged, C; Ghiasi, SM; Karlsen, K; Korsholm, KS; Mortensen, R	1
Agger, EM; Andersen, P; Andreasen, LV; Christensen, D; Kirby, D; Perrie, Y	1
Agger, EM; Andersen, P; McNeil, SE; Perrie, Y; Rosenkrands, I	1
Andersen, P; Doherty, TM; Holten-Andersen, L; Korsholm, KS	1
Cai, H; Hu, XD; Tian, X; Zhu, YX; Zhuang, YH	1
Appelberg, R; Pais, TF; Silva, RA	1

Reviews

1 review(s) available for dimethyldioctadecylammonium and Koch's Disease

Article	Year
Liposome-based cationic adjuvant formulations (CAF): past, present, and future. Journal of liposome research, 2009, Volume: 19, Issue:1 Topics: Adjuvants, Immunologic; Animals; Humans; Liposomes; Quaternary Ammonium Compounds; Tuberculosis; Tuberculosis Vaccines	2009

Other Studies

8 other study(ies) available for dimethyldioctadecylammonium and Koch's Disease

Article	Year
Scale-Independent Microfluidic Production of Cationic Liposomal Adjuvants and Development of Enhanced Lymphatic Targeting Strategies. Molecular pharmaceutics, 2019, 10-07, Volume: 16, Issue:10 Topics: Adjuvants, Immunologic; Animals; Antigens, Bacterial; Cations; Female; Immunization; Liposomes; Lymph Nodes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microfluidics; Quaternary Ammonium Compounds; Tissue Distribution; Tuberculosis; Tuberculosis Vaccines	2019
Immunogenicity and protective efficacy of multistage vaccine candidates (Mtb8.4-HspX and HspX-Mtb8.4) against Mycobacterium tuberculosis infection in mice. International immunopharmacology, 2017, Volume: 53 Topics: Adjuvants, Immunologic; Animals; Antigens, Bacterial; Bacterial Proteins; Cells, Cultured; Female; Immunization; Interferon-gamma; Leukocytes, Mononuclear; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Quaternary Ammonium Compounds; Tuberculosis; Tuberculosis Vaccines; Tumor Necrosis Factor-alpha; Vaccines, Subunit	2017
Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV. Artificial cells, nanomedicine, and biotechnology, 2019, Volume: 47, Issue:1 Topics: Animals; Antigens, Bacterial; Bacterial Proteins; BCG Vaccine; Cytokines; Glycolipids; Liposomes; Mice; Quaternary Ammonium Compounds; Tuberculosis; Virulence Factors	2019
A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4⁺ T-cell response. Nanomedicine (London, England), 2014, Volume: 9, Issue:17 Topics: Animals; CD4-Positive T-Lymphocytes; Chemistry, Pharmaceutical; Drug Synergism; Humans; Liposomes; Mice; Monoglycerides; Mycobacterium tuberculosis; Nanoparticles; Oligodeoxyribonucleotides; Quaternary Ammonium Compounds; Tuberculosis; Vaccines	2014
Subunit vaccines: distearoylphosphatidylcholine-based liposomes entrapping antigen offer a neutral alternative to dimethyldioctadecylammonium-based cationic liposomes as an adjuvant delivery system. Journal of pharmaceutical sciences, 2011, Volume: 100, Issue:5 Topics: Adjuvants, Immunologic; Animals; Female; Glycolipids; Humans; Interferon-gamma; Liposomes; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Quaternary Ammonium Compounds; Recombinant Fusion Proteins; Tuberculosis; Tuberculosis Vaccines; Vaccines, Subunit	2011
Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines. Infection and immunity, 2004, Volume: 72, Issue:3 Topics: Adjuvants, Immunologic; Animals; Cord Factors; Female; Interferon-gamma; Kinetics; Lipid A; Mice; Mice, Inbred C57BL; Quaternary Ammonium Compounds; Surface-Active Agents; Th1 Cells; Tuberculosis; Tuberculosis Vaccines; Vaccines, Subunit	2004
Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis. DNA and cell biology, 2004, Volume: 23, Issue:7 Topics: Acyltransferases; Adjuvants, Immunologic; Animals; Antibody Formation; Antigens, Bacterial; Bacterial Proteins; BCG Vaccine; Female; Interferon-gamma; Lung; Membrane Proteins; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Plasmids; Quaternary Ammonium Compounds; Spleen; Tuberculosis; Vaccines, Combined; Vaccines, DNA	2004
Effects of interleukin-12 in the long-term protection conferred by a Mycobacterium avium subunit vaccine. Scandinavian journal of immunology, 2000, Volume: 52, Issue:6 Topics: Adjuvants, Immunologic; Animals; BCG Vaccine; Drug Combinations; Female; Interleukin-12; Mice; Mice, Inbred BALB C; Mycobacterium avium; Quaternary Ammonium Compounds; Time Factors; Tuberculosis; Vaccination; Vaccines, Subunit	2000